3 FTSE 100 dividends I’d buy during the 2020 stock market crash

Some of the biggest FTSE 100 dividends are being cut during the Covid-19 crisis. Here’s my approach to protecting long-term investing income.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’m very much a dividend investor these days, but I frequently caution that the presence of a big yield isn’t always sufficient to make a stock desirable.

That’s been hammered home recently as a string of companies have suspended their dividends in the wake of the coronavirus crisis. Although it’s affecting some that I hold myself, I think it’s a wise move to focus on balance sheet strength right now. But if you want the safest income you can find, what dividends should you go for?

FTSE 100 dividends

Just as we’re only allowed to shop for essentials, investing in companies that provide essentials can help secure more reliable dividends. Prime examples include utilities like Severn Trent (LSE: SVT).

Severn Trent’s share price has been reasonably resilient, losing 17% or so since the virus dip started. That’s not great, but it’s a lot better than the FTSE 100’s 26% fall – and the falls of 50% and more that riskier stocks have experienced.

Severn Trent’s dividend yield has never been one of the market’s biggest. But the share price fall has pushed the forecast yield up to 4.5% now. It’s certainly not guaranteed, and the firm’s income is not immune from the pandemic threat. But it’s surely a lot more reliable than income from companies offering more discretionary products and services.

Network services

National Grid (LSE:NG) is perhaps of even more central importance. And it’s also offers one of my favourite long-term income streams. With a fall of 14% in its share price, the market seems to see it as more resilient too. And, interestingly, National Grid shares are actually up over the past 12 months, by 4%, while the FTSE 100 has lost about a quarter of its value.

Again, the recent fall has made the dividend yield look a bit more attractive. National Grid has traditionally provided yields a little ahead of the general utility sector level, and right now we’re looking at forecasts for around 5.4%.

With operations in North America too, National Grid also offers a bit of international diversity. And that can’t be a bad thing in these restricted times.

Looking at Severn Trent and National Grid together, I’m reminded that more reliable dividends like these are not just for crisis times. No, they can always make a solid core for an income portfolio.

Long term

I also like the approach of seeking companies whose business models are necessarily directed to the long term. That includes AstraZeneca (LSE: AZN), with its multi-year drug development focus. GlaxoSmithKline fits the bill as well, but I’ll just look at one of the two today.

The AstraZeneca share price is yet another that appears resistant to the great sell-off, falling a very modest 11.5%. It’s also another that has actually gained over the past year, up 5%. As such, the recent dip hasn’t done a great deal to the forecast dividend yield, though it still stands at a respectable 3.5%.

AstraZeneca’s operations could well be hurt by the social distancing aspect of the current lockdown, and it might lose work in non-essential areas of the business. But I really don’t see a great threat to the dividend. The firm’s dividend is already keyed to its years-long earnings and balance-sheet expectations. And, in my view, it’s another example of the kind of long-term dividend we should be seeking.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended AstraZeneca. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Charticle

2 brilliant (but very different) shares I want to buy if they get cheaper in 2025!

This contrasting pair of businesses has caught our writer's eye. But he is not ready to buy the shares at…

Read more »

Investing Articles

3 steps to start buying shares with a spare £250

Christopher Ruane explains three simple but important principles he thinks people should consider when they start buying shares, even with…

Read more »

Light trails from traffic moving down The Mound in central Edinburgh, Scotland during December
Investing Articles

FTSE 100 shares: bargain hunting to get richer!

After hitting a new high this year, might the FSTE 100 still offer bargain shares to buy? Our writer thinks…

Read more »

Investing Articles

How to try and turn a £50K SIPP into a £250K retirement fund

Christopher Ruane explains how a long-term approach and careful share selection could potentially help an investor quintuple the value of…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

My £3 a day passive income plan for 2025

Christopher Ruane walks through his plan for next year and beyond of squirreling away and investing a few pounds a…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

Can the FTSE 250’s Raspberry Pi boost my portfolio over the next decade?

This British technology stock in the FTSE 250 has exploded onto the London stock market and right now its future…

Read more »

Investing Articles

Does acquiring Direct Line make Aviva shares a buy?

A big acquisition should give Aviva greater scale and profitability, increasing the value of its shares. But is it an…

Read more »

Investing Articles

After a 25% decline in 2024, this FTSE 250 stock is top of my buy list for the New Year

Stephen Wright’s top investment idea is a FTSE 250 stock that’s down 25% this year in an industry that’s under…

Read more »